Stuart Bryan 4
4 · Fulcrum Therapeutics, Inc. · Filed Apr 2, 2021
Insider Transaction Report
Form 4
Stuart Bryan
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-31+350,000→ 350,000 totalExercise: $11.78Exp: 2031-03-30→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 31, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of March 31, 2021, subject to continued service.